Emery Capital

Emery Capital is a Moscow-based venture and growth firm backing Russian and CIS technology startups from seed through late-stage rounds.

Emery Capital

Emery Capital is a Russia-based private equity firm investing in early-stage and growth-stage technology companies. The firm operates from a single office in Moscow and focuses on the domestic market and the broader Commonwealth of Independent States. The firm's investment mandate spans initial startup rounds, follow-on early-stage capital, and selective growth financing. It sources proprietary deal flow through networks of local entrepreneurs, technology incubators, and corporate partners. Emery Capital structures both direct equity investments and convertible instruments, though specific fund vehicles or separate managed accounts have not been publicly disclosed. Operational and financial scale remain opaque. No public disclosures of assets under management, total deployment, or team headcount are available. Emery Capital maintains no known presences outside Moscow, and no affiliated philanthropic entities or co-investor clubs have been reported in open sources. Emery Capital's structural differentiator is its focus on underexploited Russian and CIS technology deals at a time when many international funds remain sidelined by geopolitical restrictions. The firm's edge lies in its physical proximity to founders, its native-language operating capacity, and its ability to move without the compliance burden that constrains Western LPs active in the region.

Website

www.emery.capital

linkedin.com/company/emery-capital

General information

Firm type

Private Equity

Year founded

—

AUM

Undisclosed

Location

Region

Europe

Country

Russia

City

Moscow

Corporate office

Moscow, Russia

What investment stages does Emery Capital target?

Emery Capital operates across early-stage startup rounds, follow-on early-stage financings, and select growth-stage investments. The firm deploys capital from initial seed or Series A through later-stage rounds in companies that have demonstrated product-market fit in Russian and CIS markets. No minimum or maximum check-size ranges have been publicly disclosed.

Does Emery Capital invest exclusively in Russia?

The firm maintains its sole office in Moscow and concentrates its deal-sourcing efforts on Russian-domiciled companies. It also considers opportunities across the Commonwealth of Independent States, including Belarus, Kazakhstan, and Armenia, where shared language, legal frameworks, and business networks make cross-border execution feasible.

Is Emery Capital structured as a single-family office or independent asset manager?

Emery Capital is categorized as an independent private equity and venture capital firm. No public records suggest it operates as a family office, captive vehicle for a parent corporation, or state-affiliated investment platform. The identities of the firm's general partners and underlying limited partners have not been disclosed in English-language public sources.

How does Emery Capital source deals?

The firm's sourcing strategy is relationship-based, leveraging personal ties to Moscow-based startup founders, technology transfer offices, and local incubators. It does not operate a publicly advertised accelerator program or co-investor club that would provide external LPs with deal-flow access, and it does not appear to source through established global networks such as AngelList or Y Combinator alumni groups.

Which sectors does Emery Capital explicitly avoid?

No negative screening or sector-exclusion policy has been made public. The firm's portfolio concentration is believed to skew toward generalist technology opportunities available in the Russian-speaking world, with no evidence of dedicated biotech, hard-science, or military-technology verticals.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: May 29, 2026. Continuous refresh with full update cycles at least every 30 days.